Hims Hers Health Inc is trading 5.7% down at $26.42 as the stock undergoes a pullback following a sharp multi-day rally driven by its $1.15 billion Eucalyptus acquisition and GLP-1 strategy.
- Market analysts describe the current move as a normal consolidation of recent strength rather than a result of new negative fundamental developments.
- Broader market risk-off sentiment is likely amplifying volatility in the high-growth telehealth name as major indices also trade lower.